SHILPA MEDICARE LTD. - 530549 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Pursuant to Reg 30 of SEBI (LODR) 2015, please find the enclosed postal ballot notice together with the explanatory statement for seeking approval of members of the Company for the resolution set out therein. SHILPA MEDICARE LTD. - 530549 - Closure of Trading Window
The Trading window for dealing in securities of the Company shall remain closed for all the designated persons and their immediate relatives with effect from 01 July 2023 till 48 hours after the declaration of un-audited financial results for the quarter ended 30 June 2023 SHILPA MEDICARE LTD. - 530549 - Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On 23 June 2023
The Board of Directors of the Company('Board') at its meeting held on 23 June 2023, inter-alia considered and approved the following business items: 1. Increase of Authorized Share Capital 2. Rights issue 3. Approval of Scheme of Amalgamation with Shilpa Therapeutics Private Limited (A Wholly Owned Subsidiary Company).
Shilpa Medicare to consider rights issue on June 23
An expansion in the formulation business, new product pipeline and the monetisation of certain verticals are seen as the major growth triggers for Shilpa Medicare SHILPA MEDICARE LTD. - 530549 - Board Meeting Intimation for Meeting Of Board Of Directors Of The Company Will Be Held On Friday, June 23, 2023 To Inter-Alia Consider The Proposal Of Fund Raising By Way Of Rights Issue Of Equity Shares.
SHILPA MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/06/2023 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the company will be held on Friday, June 23, 2023 to consider inter alia, proposal of fund raising by way of Rights issue of Equity Shares, subject to such Regulatory/ Statutory approvals as may be required. In accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 read with the Company's code of conduct to Regulate, Monitor and Report trading by Designated persons, the Trading window of the SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of the Q4 Conference call SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Further to our letter dated 25 May 2023 regarding approval of Audited Standalone and Consolidated Financial Results of the Company for the quarter & year ended 31 March 2023, please find enclosed newspaper advertisements, published in compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in Sudhimoola and Business Line. SHILPA MEDICARE LTD. - 530549 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015, read with CIR/CFD/CMD1/27/2019 dated February 8, 2019, please find enclosed the Annual Secretarial Compliance Report of the Company for the financial year 2022-23 issued by Mr. D S Rao, Practicing Company Secretary. SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
In furtherance to our intimation dated 25 May 2023 with regard to the Q4 FY23 Conference Call held on Friday, 26 May 2023 at 01.00 PM IST, please note that the audio recording of the conference call has been uploaded on our website on the following web link.
Shilpa Medicare tumbles 5% as March quarter performance disappoints
Shilpa Medicare posted a net loss of Rs 8.1 crore in the March quarter. The pharma firm has reported net losses in three of the four quarters in FY23